Which studies are recommended to establish a diagnosis of cutaneous B-cell lymphoma (CBCL)?

Updated: Feb 23, 2021
  • Author: Mohammad Muhsin Chisti, MD, FACP; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

In addition to its general guidance on diagnosis of lymphoma, the NCCN recommends the following studies to establish a diagnosis of CBCL [16] :

  • Immunohistochemistry (IHC) panel: CD20, CD3, CD5, CD10, BCL2, BCL6, IRF4/MUM1

  • Additional IHC panel for subtyping: Ki-67, CD43, CD21, CD23, Cyclin D1, kappa/lambda

  • Assessment of IgM and IgD expression to distinguish between PC-FCL and PC-DLBCL, leg type

  • Fluorescence in situ hybridization (FISH) or cytogenetics for detection of t(14;18)

  • Bone marrow biopsy in PC-FCL, optional for PC-MZL

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!